#272: How Can We Build Reliability and Quality When Outsourcing Pharmacovigilance?
Chair
Principal Consultant, Pharmacovigilance and Drug Safety, Vice-President ACRES, NDA Group, United Kingdom
After his training in hospital medicine and clinical research for 14 years, Dr. Edwards joined the UK Medicines Control Agency (MHRA) in 1994 where he had various responsibilities as a pharmacovigilance assessor. In 1999 he joined Parexel to become Senior Medical Director before joining...
Read More →
Speakers
Director, Global Pharmacovigilance Case Management, Alexion
Lillian is a Doctor of Chiropractic with over 19 years’ healthcare experience, including clinical practice, teaching, drug safety/pharmacovigilance & medical affairs. The last 3 years, she provided safety expertise companywide & for external partners. She has worked to develop valuable...
Read More →
Vice President - R&D Business Development and Sales, Deloitte, United States
Kelly has more than 20 years’ experience in the areas of Quality, Pharmacovigilance, R&D, and Regulatory Affairs with large, global Biotech and Pharmaceutical companies. She is a Subject Matter Expert on the topics of process assessment and gap analyses, governance model design...
Read More →
Tuesday June 28, 2016 4:00pm - 5:15pm EDT
113B
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA